Enlightenment through smart measurements

Open menu

News & Events

Wednesday, April 21, 3:30 p.m. ET – Louis Laflamme, President and CEO, presents at Bloom Burton & Co. Healthcare Investor Conference

15 April 2021

Click on the link to register and to join on the date and hour of the presentation Wednesday, April 21, 3:30 p.m. ET – Louis Laflamme, President and CEO, presents at Bloom Burton & Co. Healthcare Investor Conference  

OpSens Announces Q2 Fiscal 2021 Financial Results and Record FFR and dPR Revenues

14 April 2021

  OpSens Announces Q2 Fiscal 2021 Financial Results and Record FFR and dPR Revenues Quebec City, Quebec, April 14, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, today reported its financial results for the second quarter of fiscal…

Read more

OpSens AWARDED INNOVATIVE TECHNOLOGY CONTRACT BY VIZIENT FOR OPTOWIRE III

7 April 2021

OPSENS AWARDED INNOVATIVE TECHNOLOGY CONTRACT BY VIZIENT FOR OPTOWIRE III  Contract awarded for products that bring improvement to health care industry   Quebec City, Quebec, April 7, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company, announced today it has been awarded an Innovative Technology  contract from Vizient, Inc.,…

Read more

OpSens to Host Second Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, April 14, 2021 – Conference call to be conducted at 11:00 am ET

6 April 2021

OpSens to Host Second Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, April 14, 2021 Conference call to be conducted at 11:00 am ET Quebec City, Quebec, April 6, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical…

Read more